1. Home
  2. NMRA vs SEMR Comparison

NMRA vs SEMR Comparison

Compare NMRA & SEMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • SEMR
  • Stock Information
  • Founded
  • NMRA 2019
  • SEMR 2008
  • Country
  • NMRA United States
  • SEMR United States
  • Employees
  • NMRA N/A
  • SEMR N/A
  • Industry
  • NMRA
  • SEMR EDP Services
  • Sector
  • NMRA
  • SEMR Technology
  • Exchange
  • NMRA Nasdaq
  • SEMR Nasdaq
  • Market Cap
  • NMRA 1.7B
  • SEMR 1.7B
  • IPO Year
  • NMRA 2023
  • SEMR 2021
  • Fundamental
  • Price
  • NMRA $2.05
  • SEMR $15.67
  • Analyst Decision
  • NMRA Strong Buy
  • SEMR Buy
  • Analyst Count
  • NMRA 6
  • SEMR 8
  • Target Price
  • NMRA $20.67
  • SEMR $17.13
  • AVG Volume (30 Days)
  • NMRA 6.3M
  • SEMR 506.5K
  • Earning Date
  • NMRA 03-06-2025
  • SEMR 03-03-2025
  • Dividend Yield
  • NMRA N/A
  • SEMR N/A
  • EPS Growth
  • NMRA N/A
  • SEMR N/A
  • EPS
  • NMRA N/A
  • SEMR 0.08
  • Revenue
  • NMRA N/A
  • SEMR $357,567,000.00
  • Revenue This Year
  • NMRA N/A
  • SEMR $24.50
  • Revenue Next Year
  • NMRA N/A
  • SEMR $20.36
  • P/E Ratio
  • NMRA N/A
  • SEMR $203.50
  • Revenue Growth
  • NMRA N/A
  • SEMR 22.01
  • 52 Week Low
  • NMRA $1.83
  • SEMR $9.64
  • 52 Week High
  • NMRA $21.00
  • SEMR $16.42
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 20.26
  • SEMR 75.79
  • Support Level
  • NMRA $2.12
  • SEMR $11.45
  • Resistance Level
  • NMRA $2.44
  • SEMR $12.10
  • Average True Range (ATR)
  • NMRA 0.39
  • SEMR 0.53
  • MACD
  • NMRA -0.31
  • SEMR 0.47
  • Stochastic Oscillator
  • NMRA 2.26
  • SEMR 95.85

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

About SEMR SEMrush Holdings Inc.

SEMrush Holdings Inc is engaged in the provision of an online visibility management software-as-a-service platform. Its platform enables subscribers to improve their online visibility and drive traffic, including on their websites and social media pages, and distribute highly relevant content to their customers on a targeted basis across various channels to drive high-quality traffic and measure the effectiveness of their digital marketing campaigns. Geographically, it generates revenues from the US, the UK, and other regions.

Share on Social Networks: